World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
24758
World Ranking
11923
National Ranking
1128

Paul Veys publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul Veys sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 405 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul Veys D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul Veys sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul Veys is affiliated with Great Ormond Street Hospital in the United Kingdom and focuses their research primarily in the field of Medicine. Their work spans several subfields, including Hematology, Immunology, Oncology, Genetics, and Public Health, Environmental and Occupational Health.

The scientist's research centers on topics such as Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, and Acute Myeloid Leukemia Research.

Paul Veys has been published frequently in the following venues:

  • Blood
  • Bone Marrow Transplantation
  • Blood Advances
  • Journal of Clinical Immunology
  • Transplantation and Cellular Therapy

Notable recent publications include:

  • Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies (2020, The Lancet)
  • Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy (2020, Biology of Blood and Marrow Transplantation)
  • CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial (2021, Nature Medicine)
  • EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity (2021, Bone Marrow Transplantation)
  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy (2021, Transplantation and Cellular Therapy)

Their collaborative work has involved frequent co-authors including:

  • Kanchan Rao
  • Robert Chiesa
  • Giovanna Lucchini
  • Persis Amrolia
  • Ajay Vora

Best Publications

  • Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells

    Waseem Qasim;Hong Zhan;Sujith Samarasinghe;Stuart Adams

  • Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

    Corinne Antoine;Susanna Müller;Andrew Cant;Marina Cavazzana-Calvo

  • Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

    Sara Ghorashian;Anne Marijn Kramer;Shimobi Onuoha;Gary Wright

  • Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

    Navneet S. Majhail;Stephanie H. Farnia;Paul A. Carpenter;Richard E. Champlin

  • Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?

    Andrew R. Gennery;Andrew R. Gennery;Mary A. Slatter;Mary A. Slatter;Laure Grandin;Pierre Taupin

  • Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study

    Daniele Moratto;Silvia Giliani;Carmem Bonfim;Evelina Mazzolari

  • Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study

    Tayfun Güngör;Pierre Teira;Mary Slatter;Georg Stussi

  • Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

    H. Bobby Gaspar;H. Bobby Gaspar;Samantha Cooray;Samantha Cooray;Kimberly C. Gilmour;Kimberly C. Gilmour;Kathryn L. Parsley;Kathryn L. Parsley

  • Long-Term Immune Reconstitution and Outcome After HLA-Nonidentical T-Cell–Depleted Bone Marrow Transplantation for Severe Combined Immunodeficiency: A European Retrospective Study of 116 Patients

    Elie Haddad;Paul Landais;Wilhelm Friedrich;Bert Gerritsen

  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease

    Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery

  • Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation : an international multicenter study

    Mieke Aldenhoven;Robert F. Wynn;Paul J. Orchard;Anne O'Meara

  • Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

    Reuben Benjamin;Reuben Benjamin;Charlotte Graham;Charlotte Graham;Deborah Yallop;Agnieszka Jozwik;Agnieszka Jozwik

  • Neonatal Diagnosis of Severe Combined Immunodeficiency Leads to Significantly Improved Survival Outcome: The Case for Newborn Screening

    Lucinda Brown;Jinhua Xu-Bayford;Zoe Allwood;Mary Slatter

  • Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

    Hulya Ozsahin;Marina Cavazzana-Calvo;Luigi D Notarangelo;Ansgar Schulz

  • Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.

    H. Bobby Gaspar;H. Bobby Gaspar;Emma Bjorkegren;Kate Parsley;Kate Parsley;Kimberly C. Gilmour;Kimberly C. Gilmour

  • BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

    Fiona L. Dignan;Robert F. Wynn;Nedim Hadzic;John Karani

  • Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

    Kanchan Rao;Persis J. Amrolia;Alison Jones;Catherine M. Cale

  • Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

    Persis J. Amrolia;Giada Muccioli-Casadei;Helen Huls;Stuart Adams

  • Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis

    Imke H. Bartelink;Arief Lalmohamed;Elisabeth M L van Reij;Christopher C. Dvorak

  • Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure.

    J J Boelens;R F Wynn;A O'Meara;P Veys

Frequent Co-Authors

Persis Amrolia
Persis Amrolia Great Ormond Street Hospital
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Mary Slatter
Mary Slatter Newcastle University
Andrew J. Cant
Andrew J. Cant Newcastle University
Austen Worth
Austen Worth Great Ormond Street Hospital
Kimberly Gilmour
Kimberly Gilmour Great Ormond Street Hospital
Alain Fischer
Alain Fischer Collège de France
Marina Cavazzana-Calvo
Marina Cavazzana-Calvo Necker-Enfants Malades Hospital
Mario Abinun
Mario Abinun Newcastle University
Arjan C. Lankester
Arjan C. Lankester Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medicine, several online degrees can accelerate your healthcare career. Choosing an online nursing school is a flexible and accessible path for those starting out or changing careers. These programs provide essential hands-on training and clinical experience—often at a lower cost than campus-based routes.

For nurses seeking advanced roles, online PhD programs nursing offer the opportunity to develop leadership in research, academia, or policy-making. Many professionals also look for the cheapest BSN programs online to fast-track their ability to take on more responsibility and earn higher salaries as RNs.

Non-nurses interested in entering the field quickly might consider direct entry nurse practitioner programs for non-nurses online. These innovative programs let you earn a master’s degree and advance to high-demand clinical roles even if your background isn’t in nursing. Choosing the right online path can set you up for long-term success and career growth in healthcare.

Best Scientists Citing Paul Veys

Trending Scientists

Recently Published Articles